Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Color Diagnostics, |
RCV000774961 | SCV000909053 | uncertain significance | Hereditary cancer-predisposing syndrome | 2019-03-16 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000774961 | SCV001178356 | uncertain significance | Hereditary cancer-predisposing syndrome | 2023-01-18 | criteria provided, single submitter | clinical testing | The p.M4L variant (also known as c.10A>T), located in coding exon 1 of the BRIP1 gene, results from an A to T substitution at nucleotide position 10. The methionine at codon 4 is replaced by leucine, an amino acid with highly similar properties. This amino acid position is poorly conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |